Central 5-hydroxytryptamine and the effects of hallucinogens and phenobarbital on operant responding in rats - PubMed (original) (raw)
Central 5-hydroxytryptamine and the effects of hallucinogens and phenobarbital on operant responding in rats
R L Commissaris et al. Pharmacol Biochem Behav. 1981 May.
Abstract
The present study was designed to examine the role of 5-hydroxytryptamine (5-HT) neurons in the behavioral effects of d-lysergic acid diethylamide (LSD), an indolealkylamine hallucinogen, 2.5-dimethoxy-4-methylamphetamine (DOM) and mescaline, phenethylamine hallucinogens, and phenobarbital, a non-hallucinogen. Male rats, maintained at 70-80% of their free-feeding weights, were trained to press a lever for food pellet reinforcement on a fixed ratio-40 operant schedule. When trained, these rats responded at a constant, rapid rate (approximately 100 responses/min) during daily 40 min test sessions. Administration of hallucinogens caused an abrupt cessation of responding (a "pause"), for some portion of the session. The duration of this pause was dose-dependent for LSD (12.5-100 micrograms/kg), DOM (0.125-1.0 mg/kg) and mescaline (7.1-14.2 mg/kg). On the other hand, phenobarbital (12.5-50 mg/kg) did not cause pausing, but resulted in slowed, erratic intrasession response rates. When the same tests were repeated in rats that had previously received an intracerebroventricular injection of 5,7-dihydroxyptamine (5,7-DHT) the dose-response curves for the pausing induced by all three hallucinogens were shifted to the left, while the behavioral disruption produced by phenobarbital was unaltered. In these animals the 5-HT but not the norepinephrine concentrations was markedly reduced in all brain regions examined. These results suggest that 5-HT neurons are involved with the behavioral effects of hallucinogens but not of phenobarbital.
Similar articles
- Neurotransmitter basis of the behavioral effects of hallucinogens.
Rech RH, Commissaris RL. Rech RH, et al. Neurosci Biobehav Rev. 1982 Winter;6(4):521-7. doi: 10.1016/0149-7634(82)90035-5. Neurosci Biobehav Rev. 1982. PMID: 6817241 - The behavioral effects of hallucinogens in rats following 5,7-dihydroxytryptamine administration into the medial forebrain bundle.
Commissaris RL, Mokler DJ, Lyness WH, Moore KE, Rech RH. Commissaris RL, et al. Pharmacol Biochem Behav. 1981 Jun;14(6):915-8. doi: 10.1016/0091-3057(81)90384-1. Pharmacol Biochem Behav. 1981. PMID: 6973157 - The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated rats.
Commissaris R, Lyness WH, Cordon JJ, Moore KE, Rech RH. Commissaris R, et al. Pharmacol Biochem Behav. 1980 Nov;13(5):621-6. doi: 10.1016/0091-3057(80)90002-7. Pharmacol Biochem Behav. 1980. PMID: 7443731 - Nerve terminal effects of indoleamine psychotomimetics on 5-hydroxytryptamine.
Halaris AE. Halaris AE. Neurosci Biobehav Rev. 1982 Winter;6(4):483-7. doi: 10.1016/0149-7634(82)90029-x. Neurosci Biobehav Rev. 1982. PMID: 6294571 Review. - Hallucinogens as discriminative stimuli.
Winter JC. Winter JC. Fed Proc. 1974 Jul;33(7):1825-32. Fed Proc. 1974. PMID: 4209212 Review. No abstract available.
Cited by
- Animal models of serotonergic psychedelics.
Hanks JB, González-Maeso J. Hanks JB, et al. ACS Chem Neurosci. 2013 Jan 16;4(1):33-42. doi: 10.1021/cn300138m. Epub 2012 Sep 24. ACS Chem Neurosci. 2013. PMID: 23336043 Free PMC article. Review.